UK Guidance on Quality and Risk Proportionality in Clinical Trials

2nd April 2026

Summary:
The UK has issued guidance on applying quality and risk proportionality in clinical trials, encouraging sponsors and investigators to tailor trial processes based on the level of risk involved. The approach focuses on prioritising participant safety and data reliability while avoiding unnecessary administrative burden. By identifying and managing critical risks effectively, the guidance supports more efficient trial design and delivery, helping to streamline research without compromising regulatory standards or ethical requirements.

Link: https://www.gov.uk/guidance/clinical-trials-for-medicines-guidance-on-quality-and-risk-proportionality

 

Back to Recent News